Using Minimization for a Complex Trial Design
Publié le
A multi-center phase II trial was conducted in just over 100 patients to compare metabolic changes in the prostate after…
Publié le
A multi-center phase II trial was conducted in just over 100 patients to compare metabolic changes in the prostate after…
Publié le
IDDI organized a webinar on DESIGN AND ANALYSIS OF PHASE II TRIALS IN ONCOLOGY. This webinar presented key concepts and…
Publié le
IDDI announces the appointment of Dr. Everardo Saad as Senior Medical Expert as of July 2014. Everardo brings over 12 years…
Publié le
IDDI, an international functional Contract Research Organisation (CRO) headquartered in Belgium, replaced its mix of a paper-based trial master file…
Publié le
A new Software for Risk-based Monitoring As biopharmaceutical sponsors search for the optimal approach to targeted monitoring and reduced Source…
Publié le
Central Statistical Monitoring of Data Quality in Clinical Trials IDDI announces publication on Central Statistical Monitoring: ‘A statistical approach to central…
Publié le
Integrated EDC IWRS system: The IWR/IVR system ID-netTM developed by IDDI now provides an interface to MARVIN, XClinical’s EDC system. …
Publié le
IDDI, announces that it has signed a collaborative agreement with I-BioStat, the Interuniversity Institute for Biostatistics and statistical Bioinformatics, which…
Publié le
Successful Partnership with Tigenix for Approval of Chondrocelect for Cartilage Repair IDDI’s contributed statistical methodology towards approval of ChondroCelect® TiGenix’s…